Observational Pregnancy Safety Study of Women Exposed to Nifurtimox During Pregnancy to Describe the Risk of Pregnancy and Maternal Complications and Other Events of Interest on the Developing Fetus, Neonate, and Infant First published 09/04/2026 Last updated 09/04/2026 EU PAS number:EUPAS1000000884 Study Planned